Medical Facilities Corporation
Simbolis: DR.TO
TSX
11.25
CADRinkos kaina šiandien
18.3685
P/E santykis
0.2414
PEG koeficientas
281.52M
MRK kapitalizacija
- 0.04%
DIV pajamingumas
Medical Facilities Corporation (DR-TO) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 24.1 | 34.9 | 61 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 62.5 | 64.6 | 67.5 | ||||||||||||||||||||
balance-sheet.row.inventory | 0 | 9 | 9.2 | 10.6 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 7.1 | 10.5 | 9.7 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 102.8 | 119.3 | 148.9 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 120.2 | 124.7 | 132.8 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 120.6 | 120.6 | 136 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 11.3 | 13.1 | 14.4 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 131.9 | 133.7 | 150.4 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | -0.1 | 258.4 | 13.4 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0.1 | 0 | 0.4 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.1 | -258.4 | 1.1 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 252.1 | 258.5 | 298.1 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 354.9 | 377.8 | 447 | ||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 23.2 | 26.4 | 23.9 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 23.5 | 19.9 | 14.8 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 93.3 | 123 | 126.1 | ||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 2.1 | 28.2 | 26.9 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 153.6 | 176.3 | 185.8 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 47.7 | 57.4 | 61.3 | ||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 236.6 | 263.1 | 267.3 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 348.1 | 353.2 | 396 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -262.8 | -275.3 | -263.8 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0.7 | 1.2 | 1.9 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 86 | 79.1 | 134.1 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 354.9 | 377.8 | 447 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 32.3 | 35.6 | 45.6 | ||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 118.3 | 114.7 | 179.7 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||
Total Investments | 0 | -0.1 | 258.4 | 13.4 | ||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 116.8 | 143 | 140.9 | ||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 92.7 | 108 | 79.9 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 44 | 12.3 | 46.5 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 21.5 | 20.8 | 26.8 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 8.3 | 5.2 | 4.4 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -0.5 | -0.7 | 0.3 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -0.5 | -6.2 | -10.4 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 1 | -2.6 | -1.2 | ||||||||||||||||||||
cash-flows.row.inventory | 0 | -0.2 | 1.4 | 0.7 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | -2.5 | 2.5 | -0.5 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 1.2 | -7.5 | -9.3 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -0.2 | 25.6 | 8.1 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -16.1 | -6.7 | -8.4 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 2.4 | 0.9 | -0.3 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -13.7 | -5.8 | -8.7 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -28.8 | -19.2 | -30.2 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -7.4 | -38.4 | -2.1 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -6.1 | -7.5 | -6.9 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -27.5 | -12.3 | -32.9 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -69.8 | -77.4 | -72.1 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -10.8 | -26.1 | -5.1 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 24.1 | 34.9 | 61 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 34.9 | 61 | 66.2 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 72.7 | 57 | 75.6 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -16.1 | -6.7 | -8.4 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 56.7 | 50.3 | 67.2 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 445.6 | 424.6 | 398.6 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 148.9 | 143.9 | 130 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 296.7 | 280.6 | 268.6 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -0.8 | 30.9 | 13.7 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 229.6 | 229.1 | 191.2 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 378.5 | 373.1 | 321.3 | ||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0.7 | 8.5 | 0.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.5 | 12.9 | 25.7 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 1.3 | -29.4 | -26.5 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -0.8 | 30.9 | 13.7 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 1.3 | -29.4 | -26.5 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.5 | 12.9 | 25.7 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 21.5 | 20.8 | 26.1 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 67.1 | 46.9 | 77.4 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 52.3 | 17.5 | 50.9 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 8.3 | 5.2 | 4.4 | ||||||||||||||||||||
income-statement-row.row.net-income | 0 | 18.5 | 12.3 | 46.5 |
Dažnai užduodami klausimai
Kas yra Medical Facilities Corporation (DR.TO) bendras turtas?
Medical Facilities Corporation (DR.TO) bendras turtas yra 354885000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.666.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 1.082.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.053.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.151.
Kas yra Medical Facilities Corporation (DR.TO) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 18503000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 116809000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 229573000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.